butyric acid has been researched along with Ovarian Neoplasms in 15 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 10 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seifrtová, M | 1 |
| Havelek, R | 2 |
| Cahlíková, L | 1 |
| Hulcová, D | 1 |
| Mazánková, N | 1 |
| Řezáčová, M | 2 |
| Mrkvicova, A | 1 |
| Chmelarova, M | 1 |
| Peterova, E | 1 |
| Baranova, I | 1 |
| Kazimirova, P | 1 |
| Rudolf, E | 1 |
| Krupitza, G | 2 |
| Harant, H | 2 |
| Dittrich, E | 1 |
| Szekeres, T | 2 |
| Huber, H | 2 |
| Dittrich, C | 2 |
| Zoref-Shani, E | 1 |
| Lavie, R | 1 |
| Bromberg, Y | 1 |
| Beery, E | 2 |
| Sidi, Y | 1 |
| Sperling, O | 1 |
| Nordenberg, J | 2 |
| Yabushita, H | 2 |
| Sartorelli, AC | 1 |
| Grill, S | 1 |
| Hulla, W | 1 |
| Götzinger, N | 1 |
| Sauter, M | 1 |
| Roemer, K | 1 |
| Mueller-Lantzsch, N | 1 |
| Noguchi, M | 1 |
| Nakanishi, M | 1 |
| Suzuki, M | 1 |
| Ma, J | 1 |
| Usui, N | 1 |
| Furugen, Y | 1 |
| Takada, M | 1 |
| Hay, FG | 2 |
| Duncan, LW | 1 |
| Langdon, SP | 2 |
| Leonard, RC | 2 |
| Nakai, T | 1 |
| Endo, K | 1 |
| Hosono, M | 1 |
| Saga, T | 1 |
| Watanabe, Y | 1 |
| Sakahara, H | 1 |
| Imai, K | 1 |
| Yachi, A | 1 |
| Kiyozuka, Y | 1 |
| Ishiwata, I | 1 |
| Brooks, SE | 1 |
| Timmerman, J | 1 |
| Lau, CC | 1 |
| Tsao, SW | 1 |
| Knapp, RC | 1 |
| Sheets, EE | 1 |
| Wasserman, L | 1 |
| Aviram, R | 1 |
| Levavi, H | 1 |
| Ovadia, J | 1 |
| Novogrodsky, A | 1 |
| Chang, CC | 1 |
| Chao, KC | 1 |
| Ng, HT | 1 |
| Hawkes, MM | 1 |
| Lawrie, SS | 1 |
| Schol, DJ | 1 |
| Hilgers, J | 1 |
| Smyth, JF | 1 |
15 other studies available for butyric acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Haemanthamine alters sodium butyrate-induced histone acetylation, p21
Topics: Acetylation; Amaryllidaceae Alkaloids; Butyric Acid; Cell Cycle; Cell Division; Cell Line, Tumor; Ch | 2017 |
The effect of sodium butyrate and cisplatin on expression of EMT markers.
Topics: Antigens, CD; Antineoplastic Agents; Butyric Acid; Cadherins; Cell Cycle; Cell Line, Tumor; Cell Pro | 2019 |
Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells.
Topics: Adenocarcinoma; Base Sequence; Blotting, Northern; Butyrates; Butyric Acid; Cell Line; Cell Nucleus; | 1995 |
Effects of differentiation-inducing agents on purine nucleotide metabolism in an ovarian cancer cell line.
Topics: Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Dimethyl Sulfoxide; Female; Guanosine | 1994 |
Effects of sodium butyrate, dimethylsulfoxide and dibutyryl cAMP on the poorly differentiated ovarian adenocarcinoma cell line AMOC-2.
Topics: Adenocarcinoma; Alkaline Phosphatase; Bucladesine; Butyrates; Butyric Acid; Cell Differentiation; Cy | 1993 |
Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells.
Topics: Adenylyl Cyclases; Butyrates; Butyric Acid; Cell Division; Cell Line; Colforsin; Cyclic AMP-Dependen | 1996 |
Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours.
Topics: Azacitidine; Butyrates; Butyric Acid; DNA Methylation; DNA, Viral; Female; Gene Products, gag; Human | 1996 |
Emergence of an irreversible differentiated subclone from the poorly differentiated ovarian adenocarcinoma cell line AMOC-2 treated with sodium butyrate.
Topics: Adenocarcinoma; Animals; Blotting, Western; Butyrates; Butyric Acid; Cell Count; Cell Differentiatio | 1997 |
[Production of CA125 in cell lines derived from human ovarian carcinoma: in relation to the cell cycle].
Topics: Antigens, Tumor-Associated, Carbohydrate; Butyrates; Butyric Acid; Cell Cycle; Cystadenocarcinoma; E | 1992 |
Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antibodies, Monoclonal; Antigens, Neoplasm; Butyrates; Butyric | 1991 |
Drug effects on CA125 antigen expression and antibody binding to cancer cells.
Topics: Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Binding Sites, Antibody; Bucladesi | 1991 |
Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433).
Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens, Tumor-Associated, Carbohydrate; Bucladesine; Butyrat | 1991 |
Sodium butyrate enhances the activities of membranal enzymes and increases drug sensitivity in a cell line from ascitic fluid of an ovarian carcinoma patient.
Topics: Alkaline Phosphatase; Ascitic Fluid; Butyrates; Butyric Acid; Cell Line; Cell Membrane; Cisplatin; D | 1989 |
Effects of sodium butyrate on the secretion of beta-2-microglobulin and calcitonin in a human ovarian cancer cell line OC-3-VGH.
Topics: Adenocarcinoma; beta 2-Microglobulin; Butyrates; Butyric Acid; Calcitonin; Cell Division; Cell Line; | 1988 |
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens, Neoplasm; Butyrates; Butyric Acid; Cell Differentiat | 1988 |